Statin Prevents Tissue Factor Expression in Human Endothelial Cells
- 16 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (15) , 1756-1759
- https://doi.org/10.1161/01.cir.0000015465.73933.3b
Abstract
Background— Tissue factor plays a pivotal role in thrombus formation in acute coronary syndromes. However, the regulatory mechanisms underlying tissue factor expression are poorly understood. Statins are effective in patients with acute coronary syndromes. Hence, the aim of this study was to clarify in human endothelial cells the signaling pathways of thrombin-induced tissue factor expression and potential inhibitory effects of statins. Methods and Results— In human aortic endothelial cells, simvastatin prevented tissue factor induction by thrombin (4 U/mL) in a concentration-dependent manner. The increase in tissue factor activity on the cell surface was also blocked by simvastatin. Simvastatin also prevented the upregulation of tissue factor expression and activity in human aortic smooth muscle cells. Mevalonate (100 μmol/L) reversed the inhibitory effect of simvastatin on tissue factor expression. Thrombin induced rapid activation of Rho A and p38 MAP kinase. The Rho-kinase inhibitor Y-27632 and the p3...Keywords
This publication has 10 references indexed in Scilit:
- The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 2000
- Thrombin signalling and protease-activated receptorsNature, 2000
- CD40 Ligation Induces Tissue Factor Expression in Human Vascular Smooth Muscle CellsThe American Journal of Pathology, 2000
- Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosisThe Journal of Pathology, 1999
- Vascular-Bed–Specific Hemostasis and Hypercoagulable StatesNew England Journal of Medicine, 1999
- Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombinJournal of Clinical Investigation, 1999
- The Efficacy and Six-Week Tolerability of Simvastatin 80 and 160 mg/DayThe American Journal of Cardiology, 1997
- Statins do more than just lower cholesterolThe Lancet, 1996
- Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol esterBiochemical Journal, 1991
- Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque.Proceedings of the National Academy of Sciences, 1989